European Healthtech startup funding raised during Q3 2024.
In Q3 2024, 95 European Healthtech companies raised a combined €1.2B across 95 funding rounds, down 68.9% versus Q3 2023. UK led by capital raised, and High-Tech Gründerfonds (HTGF) was the most active investor. Data as of 23 Aug 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Flo Health | Series C | Jul 2024 | €185M |
| Caresyntax | Series C | Aug 2024 | €164M |
| Huma | Series D+ | Jul 2024 | €73M |
| Neo Medical | Other | Sep 2024 |
8 exits.
| €61M |
| Oxford Nanopore Technologies | Other | Aug 2024 | €59M |
| Constructive Bio | Series A | Sep 2024 | €52M |
| TRIcares | Series D+ | Jul 2024 | €46M |
| Healx | Other | Aug 2024 | €44M |
| Doccla | Series B | Sep 2024 | €42M |
| PhoreMost | Series B | Sep 2024 | €39M |
| Abolis Biotechnologies | Other | Sep 2024 | €35M |
| Vandria | Series A | Aug 2024 | €28M |
| Protembis | Debt | Jul 2024 | €20M |
| Brightflow | Series A | Sep 2024 | €17M |
| Vaxdyn | Other | Sep 2024 | €15M |
